These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20100460)

  • 1. Small molecule inhibition of arylamine N-acetyltransferase Type I inhibits proliferation and invasiveness of MDA-MB-231 breast cancer cells.
    Tiang JM; Butcher NJ; Minchin RF
    Biochem Biophys Res Commun; 2010 Feb; 393(1):95-100. PubMed ID: 20100460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 as a new target of cisplatin in breast cancer cells: molecular and cellular mechanisms of inhibition.
    Ragunathan N; Dairou J; Pluvinage B; Martins M; Petit E; Janel N; Dupret JM; Rodrigues-Lima F
    Mol Pharmacol; 2008 Jun; 73(6):1761-8. PubMed ID: 18310302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and small molecule inhibition of arylamine N-acetyltransferase 1 reduces anchorage-independent growth in human breast cancer cell line MDA-MB-231.
    Stepp MW; Doll MA; Carlisle SM; States JC; Hein DW
    Mol Carcinog; 2018 Apr; 57(4):549-558. PubMed ID: 29315819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines.
    Tiang JM; Butcher NJ; Minchin RF
    Cancer Med; 2015 Apr; 4(4):565-74. PubMed ID: 25627111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
    Kang H; Mansel RE; Jiang WG
    Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for phospholipase C-gamma-mediated signaling in tumor cell invasion.
    Kassis J; Moellinger J; Lo H; Greenberg NM; Kim HG; Wells A
    Clin Cancer Res; 1999 Aug; 5(8):2251-60. PubMed ID: 10473113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors.
    Wakefield L; Robinson J; Long H; Ibbitt JC; Cooke S; Hurst HC; Sim E
    Genes Chromosomes Cancer; 2008 Feb; 47(2):118-26. PubMed ID: 17973251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms and kinetics of human arylamine N-acetyltransferase 1 inhibition by disulfiram.
    Malka F; Dairou J; Ragunathan N; Dupret JM; Rodrigues-Lima F
    FEBS J; 2009 Sep; 276(17):4900-8. PubMed ID: 19664055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular role for lysyl oxidase in breast cancer invasion.
    Kirschmann DA; Seftor EA; Fong SF; Nieva DR; Sullivan CM; Edwards EM; Sommer P; Csiszar K; Hendrix MJ
    Cancer Res; 2002 Aug; 62(15):4478-83. PubMed ID: 12154058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.
    Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z
    Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human arylamine N-acetyltransferase 1: a drug-metabolizing enzyme and a drug target?
    Rodrigues-Lima F; Dairou J; Busi F; Dupret JM
    Curr Drug Targets; 2010 Jun; 11(6):759-66. PubMed ID: 20041842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of growth and cancer-induced angiogenesis of aggressive human breast cancer cells (MDA-MB-231) on the chorioallantoic membrane of developing chicken embryos by E-peptide of pro-IGF-I.
    Chen MJ; Chiou PP; Lin P; Lin CM; Siri S; Peck K; Chen TT
    J Cell Biochem; 2007 Aug; 101(5):1316-27. PubMed ID: 17286280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human arylamine N-acetyltransferase 1: in vitro and intracellular inactivation by nitrosoarene metabolites of toxic and carcinogenic arylamines.
    Liu L; Wagner CR; Hanna PE
    Chem Res Toxicol; 2008 Oct; 21(10):2005-16. PubMed ID: 18759501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors.
    Tan M; Li P; Sun M; Yin G; Yu D
    Oncogene; 2006 Jun; 25(23):3286-95. PubMed ID: 16407820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diacylglycerol kinase is required for HGF-induced invasiveness and anchorage-independent growth of MDA-MB-231 breast cancer cells.
    Filigheddu N; Cutrupi S; Porporato PE; Riboni F; Baldanzi G; Chianale F; Fortina E; Piantanida P; De Bortoli M; Vacca G; Graziani A; Surico N
    Anticancer Res; 2007; 27(3B):1489-92. PubMed ID: 17595766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells.
    Jones JL; Shaw JA; Pringle JH; Walker RA
    J Pathol; 2003 Dec; 201(4):562-72. PubMed ID: 14648659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo.
    Jallal H; Valentino ML; Chen G; Boschelli F; Ali S; Rabbani SA
    Cancer Res; 2007 Feb; 67(4):1580-8. PubMed ID: 17308097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules.
    Nizamutdinova IT; Lee GW; Lee JS; Cho MK; Son KH; Jeon SJ; Kang SS; Kim YS; Lee JH; Seo HG; Chang KC; Kim HJ
    Carcinogenesis; 2008 Oct; 29(10):1885-92. PubMed ID: 18586687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.
    Robertson FM; Simeone AM; Mazumdar A; Shah AH; McMurray JS; Ghosh S; Cristofanilli M
    J Exp Ther Oncol; 2008; 7(4):299-312. PubMed ID: 19227010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.